# Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

Source: https://onco.cc/trials/nct00326820/  
OnCo record `nct00326820` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Ibandronic acid and Zoledronic acid in Breast cancer and Metastatic cancer, run by Wales Cancer Trials Unit, with a status the registry has not verified recently.

## Summary

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer is a phase 3 interventional study registered as NCT00326820 by Wales Cancer Trials Unit, with 1404 participants planned, started 2006-01 and due to reach its primary completion in 2012-12. Interventions recorded: ibandronate sodium, zoledronic acid, Zolendronic Acid. Conditions recorded: Breast Cancer, Hypercalcemia of Malignancy, Metastatic Cancer.

Linked to the drug Ibandronic acid because the registry names it among its interventions and Breast cancer and Metastatic cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT00326820
- Phase: 3
- Setting: Zoledronate Versus Ibandronate Comparative Evaluation: A Randomized Phase III, Open-Label, Multicenter, Parallel Group Clinical Trial to Evaluate and Compare the Efficacy, Safety Profile and Tolerability of Oral Ibandronate Versus Intravenous Zoledronate in the Treatment of Breast Cancer Patients With Bone Metastases
- Sponsor: Wales Cancer Trials Unit
- Enrolled: 1404

## Sources

- ClinicalTrials.gov NCT00326820: https://clinicaltrials.gov/study/NCT00326820

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/), [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [Ibandronic acid](https://onco.cc/drugs/ibandronic-acid/), [Zoledronic acid](https://onco.cc/drugs/zoledronic-acid/)

---
JSON: https://onco.cc/api/v1/entities/nct00326820.json